GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai OPM Biosciences Co Ltd (SHSE:688293) » Definitions » Beneish M-Score

Shanghai OPM Biosciences Co (SHSE:688293) Beneish M-Score : -1.95 (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai OPM Biosciences Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.95 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shanghai OPM Biosciences Co's Beneish M-Score or its related term are showing as below:

SHSE:688293' s Beneish M-Score Range Over the Past 10 Years
Min: -2.4   Med: -1.96   Max: -1.64
Current: -1.95

During the past 6 years, the highest Beneish M-Score of Shanghai OPM Biosciences Co was -1.64. The lowest was -2.40. And the median was -1.96.


Shanghai OPM Biosciences Co Beneish M-Score Historical Data

The historical data trend for Shanghai OPM Biosciences Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai OPM Biosciences Co Beneish M-Score Chart

Shanghai OPM Biosciences Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - - -1.88 -1.96

Shanghai OPM Biosciences Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.38 -1.64 -1.96 -1.95

Competitive Comparison of Shanghai OPM Biosciences Co's Beneish M-Score

For the Biotechnology subindustry, Shanghai OPM Biosciences Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai OPM Biosciences Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shanghai OPM Biosciences Co's Beneish M-Score falls into.



Shanghai OPM Biosciences Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shanghai OPM Biosciences Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.747+0.528 * 1.082+0.404 * 1.2321+0.892 * 0.8802+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.816+4.679 * -0.004205-0.327 * 1.0812
=-1.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ¥135.1 Mil.
Revenue was 79.707 + 71.435 + 50.441 + 53.33 = ¥254.9 Mil.
Gross Profit was 52.614 + 42.068 + 26.266 + 30.288 = ¥151.2 Mil.
Total Current Assets was ¥1,641.4 Mil.
Total Assets was ¥2,303.3 Mil.
Property, Plant and Equipment(Net PPE) was ¥300.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥50.6 Mil.
Total Current Liabilities was ¥79.7 Mil.
Long-Term Debt & Capital Lease Obligation was ¥58.5 Mil.
Net Income was 19.579 + 10.856 + 5.297 + 13.695 = ¥49.4 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was 5.657 + 23.945 + 21.681 + 7.83 = ¥59.1 Mil.
Total Receivables was ¥87.9 Mil.
Revenue was 67.918 + 71.259 + 76.392 + 74.05 = ¥289.6 Mil.
Gross Profit was 44.448 + 39.362 + 50.721 + 51.385 = ¥185.9 Mil.
Total Current Assets was ¥1,782.9 Mil.
Total Assets was ¥2,352.1 Mil.
Property, Plant and Equipment(Net PPE) was ¥270.0 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥31.6 Mil.
Total Current Liabilities was ¥70.6 Mil.
Long-Term Debt & Capital Lease Obligation was ¥59.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(135.08 / 254.913) / (87.85 / 289.619)
=0.529906 / 0.30333
=1.747

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(185.916 / 289.619) / (151.236 / 254.913)
=0.641933 / 0.593285
=1.082

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1641.389 + 300.88) / 2303.317) / (1 - (1782.852 + 270.008) / 2352.102)
=0.156751 / 0.127223
=1.2321

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=254.913 / 289.619
=0.8802

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 270.008)) / (0 / (0 + 300.88))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(50.572 / 254.913) / (31.64 / 289.619)
=0.198389 / 0.109247
=1.816

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((58.46 + 79.725) / 2303.317) / ((59.92 + 70.597) / 2352.102)
=0.059994 / 0.05549
=1.0812

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(49.427 - 0 - 59.113) / 2303.317
=-0.004205

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shanghai OPM Biosciences Co has a M-score of -1.95 suggests that the company is unlikely to be a manipulator.


Shanghai OPM Biosciences Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Shanghai OPM Biosciences Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai OPM Biosciences Co (SHSE:688293) Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Lane 908, Ziping Road, Pudong New Area, Shanghai, CHN, 201321
Shanghai OPM Biosciences Co Ltd is a biotechnology company focusing on providing cell culture solutions and end-to-end CDMO services.
Executives
Xiao Zhi Hua Director
Ni Liang Ping Director

Shanghai OPM Biosciences Co (SHSE:688293) Headlines

No Headlines